These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 13925473)

  • 1. [Treatment of the nephrotic syndrome with a spirolactone].
    VERLIAC F
    Sem Hop Ther Paris; 1961 Oct; 37():713-5. PubMed ID: 13925473
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness of the combination of spirolactone and hydroflumethiazide in the treatment of a nephrotic syndrome in an adult].
    HARTEMANN P; DEBRY G; ANTHOINE D; LAXENAIRE MJ; SCHMITT D
    Rev Med Nancy; 1961; 86():768-77. PubMed ID: 13904958
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of various nephrotic edemas with the combination of chlorothiazide and spirolactone].
    MALLET R; BOUCHARD R; PRIEUR F; GUEDON J
    Arch Fr Pediatr; 1961 Apr; 18():504-11. PubMed ID: 14468962
    [No Abstract]   [Full Text] [Related]  

  • 4. [Apropos of a pure lipoid nephrosis in a child treated with spirolactone].
    JEUNE M; SALLE B; PUGEAUT R; BONNEFOY S
    Lyon Med; 1961 May; 93():1179-83. PubMed ID: 13790026
    [No Abstract]   [Full Text] [Related]  

  • 5. [EFFECTS OF HYDROCHLOROTHIAZIDE ASSOCIATED WITH ALDOSTERONE IN THE THERAPY OF NEPHROTIC EDEMA. I. CLINICAL RESULTS AND STUDY OF WATER AND SALT METABOLISM IN 3 CASES].
    ANIBALDI A; BOSCHERINI B; PATANE E; PEDULLA T
    Prog Med (Napoli); 1963 Sep; 19():521-9. PubMed ID: 14125621
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of the edematigenous syndrome with spirolactone inhibitors of aldosterone].
    D'AMICO G; CASTELLUCCIO A
    Riforma Med; 1962 Feb; 76():154-9. PubMed ID: 13882956
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physiological bases of the utilization of aldosterone antagonists. Their clinical applications].
    VAN CAUWENBERGE H; LEFEBVRE P
    Acta Cardiol; 1962; 17():627-56. PubMed ID: 13995980
    [No Abstract]   [Full Text] [Related]  

  • 8. [ALDOSTERONE AND SPIROLACTONES IN THE CLINICAL TREATMENT OF INTERNAL DISEASES (REVIEW OF THE LITERATURE AND ANALYSIS OF PERSONAL CASES)].
    POLIANTSEVA LR; ERMOLENKO VM
    Sov Med; 1963 Dec; 27():42-51. PubMed ID: 14150357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of edematous syndromes with spirolactone S. C. 9420:6 cases].
    PUECH A; OLIVIER G; DERMENGHEM M; DUMAS R
    Montp Med; 1961; 60():31-4. PubMed ID: 14489131
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aldosterone and spirolactone].
    LABADIE P
    J Med Bord; 1961 Jun; 138():809-17. PubMed ID: 13757959
    [No Abstract]   [Full Text] [Related]  

  • 11. [A 3-year-old child having a nephrotic syndrome treated for 7 months by a spirolactone].
    VERLIAC F; BASTIN R; GUIBE C; BAROIS A
    Bull Mem Soc Med Hop Paris; 1960 Oct 14-21; 76():926-9. PubMed ID: 13780918
    [No Abstract]   [Full Text] [Related]  

  • 12. [Idiopathic edema and its treatment by aldosterone inhibitors. Effects of the spirolactone SC-9420].
    ROMANI JD
    Gaz Med Fr; 1961 Jun; 133():887-92. PubMed ID: 13743001
    [No Abstract]   [Full Text] [Related]  

  • 13. [EFFECTS OF HYDROCHLOROTHIAZIDE ASSOCIATED WITH ALDOSTERONE ANTAGONISTS IN THE THERAPY OF INFANTILE NEPHROTIC EDEMA. II. STUDY OF OSMOLAR CLEARANCES AND FREE WATER].
    ANIBALDI A; BOSCHERINI B; PAIELLA R
    Prog Med (Napoli); 1963 Sep; 19():548-52. PubMed ID: 14122942
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL TRIALS OF THE NEW ALDOSTERONE ANTAGONISTS OF A STEROID NATURE].
    KATO E; OSAWA S; WAKASUGI A; KIRIU Y; ATO T; MITSUNO K; ITAZU Y
    Chiryo; 1964; 46():1003-9. PubMed ID: 14144003
    [No Abstract]   [Full Text] [Related]  

  • 15. Spirolactone diuretics.
    WAY JL
    Wis Med J; 1961 Jul; 60():383. PubMed ID: 13783494
    [No Abstract]   [Full Text] [Related]  

  • 16. [The aldosterone-antagonistic spirolactone. I. Pharmacology].
    KRUECK F; HILD R
    Klin Wochenschr; 1960 Oct; 38():962-5. PubMed ID: 13754545
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyporeninemic hypoaldosteronism in patients with nephrotic syndrome.
    Usberti M; Gazzotti RM
    Am J Nephrol; 1998; 18(3):251-5. PubMed ID: 9627045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a spirolactone (SC-8109) in primary mineralocorticoid excess.
    KISTLER H; FRAWLEY TF
    J Clin Endocrinol Metab; 1960 Aug; 20():1158-67. PubMed ID: 14409470
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary note on the use of a spirolactone in the treatment of myasthenia].
    JEUNE M; VINCENT P; HUMBERT G; LEVRAT R
    Lyon Med; 1962 May; 94():1343-50. PubMed ID: 14451753
    [No Abstract]   [Full Text] [Related]  

  • 20. [Spirolactone, an aldosterone-antagonistic steroid. Illustration of its effects on a patient with liver cirrhosis].
    EILERSEN P; HEMPEL-JORGENSEN P
    Ugeskr Laeger; 1960 Feb; 122():252-6. PubMed ID: 13819718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.